胃溃康泰治疗溃疡病的临床研究

Clinical Research of Treating Gastroduodenal Ulceration with Weikuikangtai

对纤维胃镜检查确诊的胃、十二指肠球部溃疡（GU、DU）54例应用胃溃康泰（A组）及30例应用胶体次枸橼酸铋（B组）治疗的患者随机进行了系统的对照观察。治疗前、后均经胃镜检查、摄片，测定溃疡灶的大小及进行分期。同时进行病理活检及尿素酶法幽门螺杆菌检测。结果A组的总有效率为90．6％，B组83．3％，两组间有显著性差异（P＜0．05）。文中对胃溃康泰的作用机制进行了探讨。

Eighty four patients diagnosed as having gastric ulcer (GU) or duodenal ulcer (DU) by endoscopy were randomly divided into two groups. The fifty four patients in group A took Weikuikangtai (WKKT),and the thirty patients in group B were given colloidal bismuth subsitrate (CBS). The ulcers were measured, staged and photographed before and after the treatment, and the heliobacteria pylori (HP) were examined by urease test and biospy at the same time. The statistical analysis showed that the efficacy ratio of group A was 90. 6%, while that of group B was 83. 3%. (P<0.05). The significant difference indicates that WKKT is preferable in treating DU and GU. The analysis of the functional mechanism of WKKT is also made.